NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Absolutely!

“The difference is that we overcame the (Eden) cleaning and safety issues and now have a product that is GMP-compatible. That's major!” — beartrap

True. Arguably the most important point in yesterday’s 10Q.

They are now working on making the footprint of the units smaller, something that another poster, Antihama, said could possibly wait until Eden 1.2. The 10Q sounded like they were getting it done, since it used the past tense. Though, the more I read it, the more I think Antihama is right and that smaller footprint may be next year's roll-out model!

The Flaskworks team and Advent BioServices also continued to work with the specialized contractor on additional modifications to reduce the footprint of the GMP-compatible Flaskworks system, to enable more systems to fit into the planned Grade C labs and enable further increases in the production capacity.